Aevis Victoria SA (SWX:AEVS)
Switzerland · Delayed Price · Currency is CHF 12.40
+0.10 (0.81%)
Jul 14, 2026, 10:58 AM CET
Aevis Victoria Market Cap
Aevis Victoria has a market cap or net worth of 1.05 billion as of July 14, 2026. Its market cap has decreased by -6.49% in one year.
Market Cap
1.05B
Enterprise Value
2.01B
Revenue
1.04B
Ranking
n/a
PE Ratio
n/a
Stock Price
12.40
Market Cap Chart
Since July 5, 1999, Aevis Victoria's market cap has increased from 2.40M to 1.05B, an increase of 43,483.28%. That is a compound annual growth rate of 25.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 1.05B | -7.18% |
| Dec 30, 2025 | 1.13B | -10.38% |
| Dec 30, 2024 | 1.26B | -11.76% |
| Dec 29, 2023 | 1.42B | -3.64% |
| Dec 30, 2022 | 1.48B | 20.89% |
| Dec 30, 2021 | 1.22B | 17.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 268.27B |
| Novartis AG | 227.50B |
| Lonza Group AG | 40.93B |
| Galderma Group AG | 40.55B |
| Idorsia | 1.58B |
| PolyPeptide Group AG | 1.52B |
| SKAN Group AG | 1.28B |
| Medartis Holding AG | 1.14B |